Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria

Authors Naqvi SZ, Kiran U, Ali MI, Jamal A, Hameed A, Ahmed S, Ali N

Received 31 May 2013

Accepted for publication 9 July 2013

Published 20 August 2013 Volume 2013:8(1) Pages 3187—3195

DOI https://doi.org/10.2147/IJN.S49284

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Syed Zeeshan Haider Naqvi, Urooj Kiran, Muhammad Ishtiaq Ali, Asif Jamal, Abdul Hameed, Safia Ahmed, Naeem Ali

Microbiology Research Laboratory, Department of Microbiology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan

Abstract: Biological synthesis of nanoparticles is a growing innovative approach that is relatively cheaper and more environmentally friendly than current physicochemical processes. Among various microorganisms, fungi have been found to be comparatively more efficient in the synthesis of nanomaterials. In this research work, extracellular mycosynthesis of silver nanoparticles (AgNPs) was probed by reacting the precursor salt of silver nitrate (AgNO3) with culture filtrate of Aspergillus flavus. Initially, the mycosynthesis was regularly monitored by ultraviolet-visible spectroscopy, which showed AgNP peaks of around 400–470 nm. X-ray diffraction spectra revealed peaks of different intensities with respect to angle of diffractions (2θ) corresponding to varying configurations of AgNPs. Transmission electron micrographs further confirmed the formation of AgNPs in size ranging from 5–30 nm. Combined and individual antibacterial activities of the five conventional antibiotics and AgNPs were investigated against eight different multidrug-resistant bacterial species using the Kirby–Bauer disk-diffusion method. The decreasing order of antibacterial activity (zone of inhibition in mm) of antibiotics, AgNPs, and their conjugates against bacterial group (average) was; ciprofloxacin + AgNPs (23) > imipenem + AgNPs (21) > gentamycin + AgNPs (19) > vancomycin + AgNPs (16) > AgNPs (15) > imipenem (14) > trimethoprim + AgNPs (14) > ciprofloxacin (13) > gentamycin (11) > vancomycin (4) > trimethoprim (0). Overall, the synergistic effect of antibiotics and nanoparticles resulted in a 0.2–7.0 (average, 2.8) fold-area increase in antibacterial activity, which clearly revealed that nanoparticles can be effectively used in combination with antibiotics in order to improve their efficacy against various pathogenic microbes.

Keywords: mycosynthesis, silver nanoparticles, antibacterial agents, Aspergillus flavus

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Readers of this article also read:

Undertreatment of osteoporosis and the role of gastrointestinal events among elderly osteoporotic women with Medicare Part D drug coverage

Siris ES, Yu J, Bognar K, DeKoven M, Shrestha A, Romley JA, Modi A

Clinical Interventions in Aging 2015, 10:1813-1824

Published Date: 5 November 2015

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment

Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O

Clinical Interventions in Aging 2015, 10:1779-1788

Published Date: 3 November 2015

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia

Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, Shimizu T

Neuropsychiatric Disease and Treatment 2014, 10:1973-1978

Published Date: 15 October 2014

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder

Aoki A, Ishiguro S, Watanabe T, Ueda M, Hayashi Y, Akiyama K, Kato K, Inoue Y, Tsuchimine S, Yasui-Furukori N, Shimoda K

Neuropsychiatric Disease and Treatment 2014, 10:1793-1798

Published Date: 18 September 2014

Decreased mean platelet volume in panic disorder

Göğçegöz Gül I, Eryılmaz G, Özten E, Hızlı Sayar G

Neuropsychiatric Disease and Treatment 2014, 10:1665-1669

Published Date: 4 September 2014

Risk of epilepsy in patients with systemic lupus erythematosus – a retrospective cohort study

Tsai JD, Lin CL, Lin CC, Sung FC, Lue KH

Neuropsychiatric Disease and Treatment 2014, 10:1635-1643

Published Date: 2 September 2014

Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H

Neuropsychiatric Disease and Treatment 2014, 10:1287-1296

Published Date: 10 July 2014

A novel preparation method for silicone oil nanoemulsions and its application for coating hair with silicone

Hu Z, Liao M, Chen Y, Cai Y, Meng L, Liu Y, Lv N, Liu Z, Yuan W

International Journal of Nanomedicine 2012, 7:5719-5724

Published Date: 12 November 2012